Clinical Trial Update: RANKL Antibody for Acute Charcot Neuro-osteoarthropathy [Phase 4]

View source ↗

Summary

Phase 4 trial update on a RANKL antibody for Charcot joint of the foot (acute Charcot neuro-osteoarthropathy) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot Joint of the Foot
• Charcot Neuro-osteoarthropathy of the Foot

Drugs mentioned

• RANKL antibody

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Charcot Joint of Foot | Phase 4 | Status: COMPLETED